TWENTE study: The real-world endeavor resolute versus xience v drug-eluting stent study in Twente: Study design, rationale and objectives

M.W.Z. Basalus, K. Tandjung, K.G. van Houwelingen, M.G. Stoel, F.H.A.F. de Man, J.W. Louwerenburg, S.A.M. Saïd, G.C.M. Linssen, M.A.W.J. Kleijne, J. van der Palen, J. Huisman, P.M.J. Verhorst, C. von Birgelen

Research output: Contribution to journalArticleAcademic

8 Citations (Scopus)

Abstract

Background: New-generation drug-eluting stents (DES) may solve several problems encountered with first-generation DES, but there is a lack of prospective head-to-head comparisons between new-generation DES. In addition, the outcome of regulatory trials may not perfectly reflect the outcome in ‘real world’ patients.

Objectives: To compare the efficacy and safety of two new-generation DES in a ‘real world’ patient population.

Methods: A prospective, randomised, single-blinded clinical trial to evaluate clinical outcome after Endeavor Resolute vs. Xience V stent implantation. The primary endpoint is target vessel failure at one-year follow-up. In addition, the study comprises a two-year and an open-label five-year follow-up.
Original languageEnglish
Pages (from-to)360-364
JournalNetherlands heart journal
Volume18
Issue number7-8
DOIs
Publication statusPublished - 2010

Keywords

  • METIS-272829

Fingerprint Dive into the research topics of 'TWENTE study: The real-world endeavor resolute versus xience v drug-eluting stent study in Twente: Study design, rationale and objectives'. Together they form a unique fingerprint.

Cite this